We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-4.66%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12.5B
AUM Growth
-$1.66B
Cap. Flow
-$1.45B
Cap. Flow %
-11.6%
Top 10 Hldgs %
32.88%
Holding
1,206
New
194
Increased
593
Reduced
261
Closed
41

Sector Composition

Rank Sector Weight
1 Real Estate 73.13%
2 Industrials 4.58%
3 Technology 4.24%
4 Financials 3.1%
5 Healthcare 2.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ECYT
1126
DELISTED
Endocyte, Inc. Common Stock
ECYT
$2K ﹤0.01%
+265
New +$1.46K
CORI
1127
DELISTED
Corium International, Inc.
CORI
$2K ﹤0.01%
+198
New +$2.39K
ARDX icon
1128
Ardelyx
ARDX
$1.27B
$1K ﹤0.01%
+263
New +$1.64K
CRIS icon
1129
Curis
CRIS
$9.3M
0
CRVS icon
1130
Corvus Pharmaceuticals
CRVS
$1.12B
$1K ﹤0.01%
+116
New +$1.1K
FBRX icon
1131
Forte Biosciences
FBRX
$1.57B
0
MNKD icon
1132
MannKind Corp
MNKD
$1.26B
$1K ﹤0.01%
+647
New +$1.74K
NAVI icon
1133
Navient
NAVI
$805M
$1K ﹤0.01%
55
NERV icon
1134
Minerva Neurosciences
NERV
$193M
$1K ﹤0.01%
+27
New +$1.3K
PACB icon
1135
Pacific Biosciences
PACB
$419M
$1K ﹤0.01%
+642
New +$1.67K
VCYT icon
1136
Veracyte
VCYT
$4.43B
$1K ﹤0.01%
+188
New +$1.16K
WHLR
1137
Wheeler Real Estate Investment Trust
WHLR
$1.11M
0
CMRX
1138
DELISTED
Chimerix, Inc.
CMRX
$1K ﹤0.01%
+260
New +$1.32K
LUMO
1139
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$1K ﹤0.01%
+23
New +$1.63K
MRNS
1140
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$1K ﹤0.01%
+56
New +$1.33K
NSTG
1141
DELISTED
NanoString Technologies, Inc.
NSTG
$1K ﹤0.01%
+140
New +$1.02K
BLCM
1142
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$1K ﹤0.01%
+18
New +$1.36K
SIOX
1143
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$1K ﹤0.01%
+74
New +$1.19K
CALA
1144
DELISTED
Calithera Biosciences, Inc
CALA
$1K ﹤0.01%
+10
New +$1.56K
TLGT
1145
DELISTED
Teligent, Inc
TLGT
$1K ﹤0.01%
+30
New +$954
NEOS
1146
DELISTED
Neos Therapeutics, Inc
NEOS
$1K ﹤0.01%
+160
New +$1.53K
NBRV
1147
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$1K ﹤0.01%
+1
New +$1.48K
TTPH
1148
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$1K ﹤0.01%
+14
New +$1.23K
RARX
1149
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$1K ﹤0.01%
+125
New +$893
FOMX
1150
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$1K ﹤0.01%
+207
New +$1.25K

Similar funds

Daiwa Securities Group's Q1 2018 Portfolio in Review

As of Q1 2018, Daiwa Securities Group held 1,206 positions worth $12.5B, down 12% from $14.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Daiwa Securities Group withdrew a net $1.45B in Q1 2018, closing 41 positions and reducing 261 holdings. Its most notable exit was Anthem, Inc., an estimated $25.2M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 73% of assets, down from 77% a quarter earlier, followed by Industrials and Technology.

Against the trend, Daiwa Securities Group opened a new position in Supernus Pharmaceuticals worth $3.16M.

  • Daiwa Securities Group's largest Q1 2018 buy was Supernus Pharmaceuticals: 68,983 shares worth $3.16M.
  • Daiwa Securities Group added most to Boston Properties in Q1 2018, an estimated $165M increase.
  • Daiwa Securities Group's biggest Q1 2018 reduction was Simon Property Group, cutting an estimated $275M.
  • Daiwa Securities Group fully exited Anthem, Inc. in Q1 2018, selling an estimated $25.2M.
  • Daiwa Securities Group's ten largest holdings make up 33% of its $12.5B portfolio in Q1 2018.
  • Daiwa Securities Group opened 194 new positions and closed 41 in Q1 2018.
  • Daiwa Securities Group's portfolio value fell 12% quarter-over-quarter to $12.5B.

Based on Daiwa Securities Group's 13F filing for Q1 2018, filed 2 May 2018.